JUNO PHARMACEUTICALS CORP — Ketorolac Importer Profile
Pharmaceutical Importer · #13 buyer for Ketorolac · $1.8M import value · 46 shipments · CANADA · DGFT Verified
JUNO PHARMACEUTICALS CORP is the #13 importer of Ketorolac from India with $1.8M in import value and 46 verified shipments. JUNO PHARMACEUTICALS CORP holds a 1.5% market share in Ketorolac imports based in CANADA. The company sources from 1 verified supplier across 9 formulations shipped to 1 country.
JUNO PHARMACEUTICALS CORP — Ketorolac Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Ketorolac to JUNO PHARMACEUTICALS CORP?
Verified from 46 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GLAND PHARMA LIMITED | $1.8M | 46 | 100.0% |
JUNO PHARMACEUTICALS CORP sources Ketorolac from 1 verified Indian supplier based on 46 customs records. The primary supplier is GLAND PHARMA LIMITED accounting for 100.0% of imports.
How Does JUNO PHARMACEUTICALS CORP Compare to Nearest Ketorolac Importers?
Buyers ranked immediately above and below #13 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | AO RANBAXY | RUSSIA | $2.8M | 56 | $50.0K |
| 12 | NORTHSTAR DISTRIBUTION CENTER | UNITED STATES | $1.9M | 39 | $50.0K |
| 13 | JUNO PHARMACEUTICALS CORP ★ | CANADA | $1.7M | 36 | $47.3K |
| 2 | AO "RANBAXY" | RUSSIA | $1.7M | 34 | $50.0K |
| 8 | J. KNIPPER & COMPANY | UNITED STATES | $1.5M | 30 | $50.0K |
JUNO PHARMACEUTICALS CORP ranks #13 among 638 Ketorolac importers from India. Average shipment value of $47.3K compared to the market average of $57.3K. The closest competitors by value are AO RANBAXY and NORTHSTAR DISTRIBUTION CENTER.
Where Does JUNO PHARMACEUTICALS CORP Import Ketorolac To?
Destination countries from 46 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| CANADA | $1.8M | 46 | 100.0% |
JUNO PHARMACEUTICALS CORP imports Ketorolac to 1 country. The primary destination is CANADA receiving 100.0% of shipments worth $1.8M.
What Ketorolac Formulations Does JUNO PHARMACEUTICALS CORP Import?
| Formulation | Value | Shipments |
|---|---|---|
| KETOROLAC TROMETHAMINE INJECTION 30MG/ML(30MG/ML) | $751.2K | 21 |
| KETOROLAC TROMETHAMINE INJECTION 30MG ML 30MG ML | $300.0K | 6 |
| KETOROLAC TROMETHAMINE INJECTION 30MG/ML30MG/ML | $250.0K | 5 |
| KETOROLAC TROMETHAMINE INJECTION 30MG/ML | $243.9K | 5 |
| KETOROLAC TROMETHAMINE INJECTION 30MG/ML, (30MG/ML)NOS | $51.8K | 3 |
| KETOROLAC TROMETHAMINE INJECTION USP 30M | $50.0K | 1 |
| KETOROLAC THOMETHAMINE INJECTION 30MG/ML(30MG/ML)BATCH NO: A1460053 | $50.0K | 1 |
| KETOROLAC THOMETHAMINE INJECTION 30MG/ML(30MG/ML)BATCH NO: A1460054 | $49.5K | 1 |
| KETOROLAC TROMETHAMINE INJECTION 30MG/ML(30MG/ML)NOS | $48.6K | 3 |
JUNO PHARMACEUTICALS CORP imports 9 distinct Ketorolac formulations from India. The top formulation is KETOROLAC TROMETHAMINE INJECTION 30MG/ML(30MG/ML) with 21 shipments worth $751.2K.
Regulatory Requirements: Importing Ketorolac into Canada
What JUNO PHARMACEUTICALS CORP and other importers must comply with to import Ketorolac from India
Regulatory Authority
Health Canada (HC)
Approval Process for Generic Ketorolac
Abbreviated New Drug Submission (ANDS) referencing an approved Canadian Reference Product. Comparative bioavailability study required.
Typical timeline: 12–18 months
GMP Requirements
Health Canada GMP (GUI-0001); on-site Drug Establishment Licence (DEL) inspection
Import Licence & Documentation
Drug Establishment Licence (DEL) for importer; Drug Identification Number (DIN) required
Labeling & Packaging
Bilingual (English/French) labeling required; Canadian format per Health Canada guidance
Note: Subject to C.01.014.6 annual review and Good Import Practices requirements.
Regulatory information is provided for general reference based on publicly available HC guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with HC or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Ketorolac from India and How Much Does JUNO PHARMACEUTICALS CORP Import?
India exported $36.6M worth of Ketorolac through 2,961 shipments from 351 suppliers to 124 countries, serving 638 buyers globally. JUNO PHARMACEUTICALS CORP imports $1.8M of this total, accounting for 1.5% of India's Ketorolac exports with 46 shipments from CANADA. This is verified from 46 customs shipment records covering 9 distinct formulations.
What Is the Average Order Value for JUNO PHARMACEUTICALS CORP's Ketorolac Imports?
JUNO PHARMACEUTICALS CORP's average Ketorolac order value is $39.0K per consignment, based on 46 shipments totaling $1.8M. JUNO PHARMACEUTICALS CORP is based in CANADA and ranks #13 among all Ketorolac importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Ketorolac to JUNO PHARMACEUTICALS CORP?
JUNO PHARMACEUTICALS CORP sources Ketorolac from 1 verified Indian supplier: GLAND PHARMA LIMITED ($1.8M, 100.0%). This is based on 46 customs records.
How Does JUNO PHARMACEUTICALS CORP Compare to Other Ketorolac Importers?
JUNO PHARMACEUTICALS CORP ranks #13 among 638 Ketorolac importers from India with a 1.5% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($12.4M), BAXTER HEALTHCARE CORPORATION ($6.0M), AO RANBAXY ($2.8M). JUNO PHARMACEUTICALS CORP processed 46 shipments from CANADA.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ketorolac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ketorolac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: JUNO PHARMACEUTICALS CORP matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as JUNO PHARMACEUTICALS CORP's capped import value divided by total capped export value for Ketorolac across all Indian exporters.
- 5.Verified Records: This page is backed by 46 individual customs records matching JUNO PHARMACEUTICALS CORP importing Ketorolac, covering 9 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 124+ countries, 638+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ketorolac Import Data for JUNO PHARMACEUTICALS CORP
Access order-level details, pricing data, supplier connections, and competitive analysis for JUNO PHARMACEUTICALS CORP's Ketorolac imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
JUNO PHARMACEUTICALS CORP
Company Profile
Multiple products · $0 total trade · Multiple categories
JUNO PHARMACEUTICALS CORP × Ketorolac
Verified from customs records
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for JUNO PHARMACEUTICALS CORP.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ketorolac. For current order-level data, contact TransData Nexus.